Literature DB >> 21417187

Intravitreal Ranibizumab for Choroidal Neovascularization in Best's Vitelliform Macular Dystrophy in a 6-Year-Old Boy.

Fatemeh Heidary, Wan Hazabbah Wan Hitam, Nor Fariza Ngah, Tara Mary George, Hanizasurana Hashim, Ismail Shatriah.   

Abstract

A 6-year-old boy with a family history of Best's vitelliform macular dystrophy presented with a unilateral choroidal neovascularization. He responded well to a single injection of intravitreal ranibizumab. His visual acuity improved from 6/18 to 6/9 in the affected eye. His condition remained stable for 1½ years after treatment. Copyright 2011, SLACK Incorporated.

Entities:  

Year:  2011        PMID: 21417187     DOI: 10.3928/01913913-20110308-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  1 in total

1.  Choroidal neovascularization secondary to Best's vitelliform macular dystrophy in two siblings of a Malay family.

Authors:  Koh Alisa-Victoria; Tan Jin-Poi; Ismail Shatriah; Embong Zunaina; Nor Fariza Ngah
Journal:  Clin Ophthalmol       Date:  2014-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.